Donga ST announced that Marketing Authorization Application of superbacteria-target antibiotics ‘Tedizolid phosphate’ passed preliminary examination
On March 3, Donga ST announced that Marketing Authorization Application of superbacteria-target antibiotics ‘Tedizolid phosphate’ with indication of complicated Skin and Soft Tissue Infections, passed preliminary examination of European Medicines Agency. Donga ST had exported technology of Tedizo...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
